The following clinical trials and studies are available. For more information or questions regarding our clinical trials, please email us.
Prospective study of the relationship between chemotherapy dose intensity and mortality in early-stage (I-II) breast cancer patients.
A phase II randomized controlled trial of genomically directed therapy after preoperative chemotherapy in patients with triple negative breast cancer.
Randomized phase II open label study of Lenalidomide R-Chop (R2CHOP Vs RCHOP (Rituximab_Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in patients with newly diagnosed diffuse large B cell Lymphoma.
A Disease Registry for patients with chronic Lymphocytic Leukemia
Reveal study is a Prospective observational study of patients with polycythemia Vera in US clinical practices; to describe the clinical burden of PV, and to Describe health care resources utilization associated with the management of PV.
can lron lessen anemia due to cancer and chemotherapy. A multi-center, randomized, double-blind, study to investigate controlled the efficacy and safety of injectafer (ferric carboxymaltose injection).
Our Clinical Trials Staff:
Carol Barrett, R.N
At Antietam Oncology, we are committed to advancing cancer research and providing
cutting-edge treatments to our patients. Our clinical trials are a crucial part of this mission, offering new hope and possibilities in the fight against cancer.